Skip navigation
logo
(AFX UK Focus) 2009-06-30 17:44
BRIEF-US FDA panel backs limits for over-the-counter acetaminophen
Article layout: raw

WASHINGTON, June 30 (Reuters) - A U.S. Food and Drug Administration advisory panel on Tuesday:

  • VOTED 21-16 IN FAVOR OF REDUCING THE MAXIMUM ALLOWED DOSING FOR
    over-the-counter acetaminophen products and other products containing
    the painkiller

  • VOTED 24-13 IN FAVOR OF LIMITING THE MAXIMUM SINGLE ADULT DOSE OF
    acetaminophen products to 650 milligrams

  • VOTED 26-11 IN FAVOR OF SWITCHING THE CURRENT MAXIMUM ACETAMINOPHEN DOSES AVAILABLE OVER-THE-COUNTER TO PRESCRIPTION USE

  • THE PANEL IS SCHEDULED TO VOTE THIS AFTERNOON ON WHETHER TO REMOVE OVER-THE-COUNTER AND PRESCRIPTION COUGH, COLD AND OTHER MEDICATION THAT INCLUDE THE INGREDIENT

  • THE FDA IS WEIGHING OPTIONS TO HELP LIMIT THE RISK OF OVERDOSE WITH ACETAMINOPHEN THAT CAN LEAD TO POSSIBLE LIVER DAMAGE OR RELATED DEATH. THE AGENCY WILL WEIGH THE PANEL'S RECOMMENDATIONS BEFORE MAKING ANY FINAL DECISIONS. (Company news desk in Washington; +1 202 898 8400, washington.newsroom@reuters.com)

    COPYRIGHT

    Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.

    		•
    Re-organisations, re-structurings, name changes, AGM, EGM
    Government ministries
    General news
    Political news
    Article layout: raw
    Jump back to site navigation